[Event Report] WHO Regional Committee for the Western Pacific Related Event: “AMR: A Global Health Crisis” (September 25, 2021)
date : 4/13/2022
Tags: AMR
*A video of the Symposium has been published on April 13, 2022.
*A report on the Symposium has been published on April 2, 2022.
AMR Alliance Japan (Secretariat: Health and Global Policy Institute) hosted a WHO Regional Committee for the Western Pacific Related Event: “AMR: A Global Health Crisis”
Antimicrobial resistance (AMR) occurs when the microorganisms that cause infectious disease grow resistant over time to the antimicrobials used to treat them. If not enough is done to combat this problem, it is estimated that AMR will cause more deaths than cancer by 2050. Urgent action is needed.
In celebration of the 72nd session of the WHO Regional Committee for the Western Pacific to be held in Himeji in October, this symposium shared the current state of AMR-related issues within Japan and overseas, and discussed future countermeasures.
You can watch the day’s proceedings below.
[Overview]
■Date and Time: Saturday, September 25, 2021, from 16:00-18:00 JST
■Language: Japanese and English (Simultaneous Interpretation will be available)
■Venue:
– Online Participation (Zoom Webinar)
– Himeji Venue
■Participation fee: Free
■Organizers: AMR Alliance Japan, Himeji City, Himeji Medical Association, Himeji Dental Association
■Supported by: Ministry of Health, Labour and Welfare (TBD), Himeji Pharmacist Association, Hyogo Nursing Association Seiban Branch
■Sponsor: Japan Pharmaceutical Manufacturers Association
[Program] (Titles Omitted)
15:50-15:55 Greetings (For Himeji Venue Only)
Etsuji Ishibashi (Chairman, Himeji Medical Association)
16:00-16:05 Opening Remarks and Introduction
Ryoji Noritake (CEO, Boad Member, Health and Global Policy Institute)
16:05-16:25 Message
Takeshi Kasai (Regional Director for the Western Pacific, World Health Organization (WHO) )
Yasuhisa Shiozaki (Member of the House of Representatives; Former Minister of Health, Labour and Welfare; Member, Global Leaders Group on Antimicrobial Resistance; Chairman, Special Mission Committee on Data Health Advancement, Liberal Democratic Party of Japan(LDP))
Shigeru Omi (President, Japan Community Health care Organization (JCHO); Chairperson, Committee for the Promotion of Pandemic Influenza and New Infectious Disease Preparedness and Response)
16:25-16:40 Lecture 1 “AMR as a Global Health Crisis: A message from the United Kingdom”
Dame Sally Davies (UK Special Envoy on Antimicrobial Resistance)
16:40-16:55 Lecture 2 “AMR in Japan and Expectations toward Future”
Norio Ohmagari (Disease Control and Prevention Center, National Center for Global Health and Medicine (NCGM); Director, AMR Clinical Reference Center, NCGM)
16:55-17:55 Panel Discussion: Antimicrobial Stewardship
Panelists:
Socorro Escalante (Regional Coordinator for the programme on Essential Medicines and Health Technologies (EMT) and antimicrobial resistance (AMR), Western Pacific Regional Office, WHO)
Norio Ohmagari (Disease Control and Prevention Center, National Center for Global Health and Medicine (NCGM); Director, AMR Clinical Reference Center, NCGM)
Testuji Kawamura (Director, NHO Himeji Medical Center)
Kyoko Ama (Representative, Children and Healthcare Project; Fellow, Health and Global Policy Institute)
Takeshi Enami (Director, Tuberculosis and Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare)
Hajime Inoue (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare)
Tetsuya Ito (Chair, International Affairs Committee, Japan Pharmaceutical Manufacturers Association)
Moderator:
Ryoji Noritake (CEO, Boad Member, Health and Global Policy Institute)
17:55 -18:00 Closing Remarks
Hideyasu Kiyomoto (Mayor of Himeji City)
Top Research & Recommendations Posts
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] HGPI Planetary Health Policy Team Joins Call for Global Fossil Fuel Non-proliferation Treaty (October 18, 2022)
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-03-04
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Issues Surrounding and Necessary Measures Against Obesity Disease” (February 2, 2024)
-
2024-03-05
[HGPI Policy Column] (No.41) – From the Mental Health Project Team – Mental Health Policy in Japan – History and Future Policy Topics (Part 1 of HGPI Activities for Mental Health and Domestic Policy History)
-
2024-03-18
[Registration Open] International Symposium “Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (April 9, 2024)
-
2024-03-22
[Registration Open] (Hybrid Format) The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Expert Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine (April 4, 2024)
-
2024-03-26
[Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)